Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 21, 2006; 12(19): 3006-3014
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3006
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3006
Figure 2 A time course HBsAg profile (ELISA) of transduced HepG2 cells, treated with variable doses of lamivudine and IFN-γ.
A: Effect of lamivudine used at concentrations of 0.02, 0.2, and 2.0 μmol/L; B: Effect of IFN-γ used at concentrations of 0.1, 1.0 and 5.0 μg/L.
- Citation: Parvez MK, Sehgal D, Sarin SK, Basir SF, Jameel S. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-γ. World J Gastroenterol 2006; 12(19): 3006-3014
- URL: https://www.wjgnet.com/1007-9327/full/v12/i19/3006.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i19.3006